Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Phospho-CDK1/2 (Thr161, 160) Antibody (5T750) is a Rabbit antibody targeting Phospho-CDK1/2 (Thr161, 160). Anti-Phospho-CDK1/2 (Thr161, 160) Antibody (5T750) can be used in WB.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 μL | $369 | 7-10 days | 7-10 days | |
| 100 μL | $677 | 7-10 days | 7-10 days |
| Description | Anti-Phospho-CDK1/2 (Thr161, 160) Antibody (5T750) is a Rabbit antibody targeting Phospho-CDK1/2 (Thr161, 160). Anti-Phospho-CDK1/2 (Thr161, 160) Antibody (5T750) can be used in WB. |
| Synonyms | p-CDK1/2 (Thr161, 160), p-CDK1/2 (T161, 160), P34CDC2, p34 protein kinase, p33 protein kinase, Cyclin-dependent kinase 2, Cyclin-dependent kinase 1, Cell division protein kinase 2, Cell division protein kinase 1, Cell division control protein 2 homolog, CDKN2, CDKN1, CDK1/2 (p-Thr161, 160), CDK1/2 (p-T161, 160), CDC28A, CDC2 |
| Ig Type | IgG |
| Clone | 5T750 |
| Reactivity | Human |
| Specificity | Phospho-CDK1/2 (Thr161, 160) |
| Verified Activity | Western blot analysis of Phospho-CDK2(T160)+CDK1(T161) expression in HeLa treated with nocodazole cell lysate. |
| Application | |
| Recommended Dose | WB: 1:1000-1:2000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Purification | Affinity-chromatography |
| Appearance | Liquid |
| Formulation | Supplied in 10 mM phosphate buffered saline, pH 7.4, 150 mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Research Background | Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. |
| Conjucates | Unconjugated |
| Immunogen | A synthesized peptide: human CDK1 around the phosphorylation site of T161 |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.